About OPTM Healthcare
Founded by Dr. Apurba Ganguly, OPTM Healthcare revolutionizes chronic pain treatment by combining AI diagnostics with evidence-based phytomedicine.
Dr. Apurba Ganguly
Ph.D. Biochemistry, M.Sc, M.D, Ph.D. (Pain & Phytomedicine)
He Was Told It Couldn't Be Done. He Did It Anyway.
In the 1980s, Dr. Apurba Ganguly — a PhD biochemist with a relentless obsession with why — started asking a question nobody else was asking: "What if chronic joint pain isn't primarily a joint problem?" Three decades, 100,000+ patients, and a European Medical Association award later, he has his answer. And yours.
His research uncovered that most musculoskeletal pain begins with hidden muscle degeneration — a condition he termed MD-OADs — that standard MRIs and X-rays completely miss. His response? Build an AI that doesn't miss it. And then develop the world's most targeted plant-molecular therapy to reverse it.
We Started Because the System Was Failing Real People
Since 1989, one question has driven everything we do: what if we could give people their lives back — without surgery, without steroids, and without a lifetime of painkillers?
Our Mission
To make precision, AI-driven pain treatment accessible to every patient across India — not just the privileged few. We believe nobody should have to choose between living in pain and risking their life on an operating table. So we built a third option: science-backed, root-cause treatment that works. For real people. With real results.
Our Vision
To create a world where chronic pain is no longer accepted as a life sentence — where every patient has access to AI-powered precision medicine that identifies the root cause of their suffering and delivers lasting relief without drugs, injections, or surgery.
The Four Things We'll Never Compromise On
These aren't values we put on a poster. They're the reason 100,000+ patients trusted us with their health.
Scientific Excellence
97% AI accuracy backed by 45+ years of biochemistry research.
Patient-Centered Care
Personalized treatment based on your unique biomarker profile.
Evidence-Based Medicine
Every protocol backed by peer-reviewed research and clinical trials.
Global Recognition
International awards and accreditation from leading medical bodies.
Published Medical Journals & Research
Dr. Apurba Ganguly's 45+ years of clinical research is documented across 120+ peer-reviewed publications in international medical journals — indexed on NIH/PubMed, ResearchGate, IABCR, and more. Every claim OPTM makes is backed by verifiable science.
NIH / PubMed Central (2025)
Molecular Signatures of Varicosity: Diagnostic Insights from Ten Biomarker Panels
Dr. Ganguly's landmark 2025 NIH-indexed research demonstrating how a ten-panel biomarker approach provides superior diagnostic accuracy for vascular and musculoskeletal conditions — the same methodology powering OPTM's Bio-Musculo Index.
IABCR — Systematic Meta-Analysis (2024)
Efficacy of Phytotherapeutic Protocol for Risk Factor Reduction in Musculoskeletal Degeneration
A peer-reviewed systematic meta-analysis confirming that OPTM's phytotherapeutic protocol significantly reduces musculoskeletal degeneration risk factors — published in the International Archives of BioMedical and Clinical Research.
IOMC Proceedings — Clinical Research
Pain Diagnostic Protocol and Topical Phytotherapeutic Treatment for Osteoarthritic Disorders and Prevention
Clinical evidence demonstrating how OPTM's proprietary pain diagnostic protocol combined with topical phytotherapy provides measurable relief and prevention outcomes for osteoarthritic disorders.
Journal of Drug Delivery & Therapeutics (JDDT)
Phytotherapeutic Formulation for Musculoskeletal Conditions
Peer-reviewed research on the drug delivery mechanisms of OPTM's nano-concentrated plant compounds, demonstrating targeted delivery and efficacy for chronic musculoskeletal pain.
International Journal of Pharmacognosy (IJP)
Phytomedicine Clinical Application Study
Pharmacognosy research published in IJP validating the botanical ingredients and formulation science behind OPTM's phytotherapy protocol for musculoskeletal disorders.
European Journal of Pharmaceutical & Medical Research (EJPMR)
Phytomedicine Clinical Study — European Peer Review
European peer-reviewed validation of Dr. Ganguly's phytomedicine findings, providing international scientific credibility to OPTM's treatment protocols.
Journal of Orthopaedics Research (Avens Publishing)
Phytomolecular Treatment for Orthopaedic Joint Disorders
Orthopaedics-focused peer-reviewed study directly supporting OPTM's non-surgical joint treatment outcomes, published in Avens Publishing's Journal of Orthopaedics Research.
Longdom Publishing SL — Journal Series
Clinical & Cellular Immunology, Healthy Aging & Cell Science Journal Publications
Multiple peer-reviewed papers across Longdom's journal network covering nano-phyto compound immunological effects, cytokine pathway modulation, and healthy aging applications.
Rheumatology Conference Series — International Speaker (2016)
Nano-Phyto Pharmacy Approach to Musculoskeletal Conditions
Dr. Ganguly's invited speaker session at an international Rheumatology conference presenting the nano-phyto pharmacy research that laid the groundwork for OPTM's current treatment platform.
View Dr. Ganguly's Full Publication Portfolio
120+ peer-reviewed publications indexed across international research databases
Ready to Find Out What's Actually Causing Your Pain?
For ₹990, you get a complete AI biomarker assessment, a one-on-one consultation with a pain specialist, and a personalised report that explains — in plain language — exactly what's going on in your body and what we can do about it. No pressure. No obligation. Just answers.
Includes AI Diagnosis + Expert Consultation + Full Health Report